Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 28;13(10):e240221.
doi: 10.1530/EC-24-0221. Print 2024 Oct 1.

Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literature

Affiliations

Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literature

Alessandro Barbato et al. Endocr Connect. .

Abstract

Context: Cytochrome C oxidase (COX) is the fourth component of the respiratory chain and is located within the internal membrane of mitochondria. COX deficiency causes an inherited mitochondrial disease with significant genetic and phenotypic heterogeneity. Four clinical subtypes have been identified, each with distinct phenotypes and genetic variants. Mitochondrial complex IV deficiency nuclear type 4 (MC4DN4) is a form of COX deficiency associated with pathogenic variants in the SCO1 gene.

Case description: We describe three patients with MC4DN4 with developmental and epileptic encephalopathy (DEE), hypopituitarism, and SCO1 pathogenic variants. These patients' phenotypes considerably differ from previously reported MC4DN4 phenotypes as they associate DEE with progressive hypopituitarism and survival beyond the first months after birth. Pituitary deficiency in these patients progressively worsened and mainly involved growth hormone secretion and thyroid function.

Conclusions: Our findings expand knowledge of phenotypic variability in MC4DN4 and suggest that SCO1 is a candidate gene for genetic hypopituitarism and DEE.

Significance statement: Our paper describes three patients affected by MC4DN4 with hypopituitarism and developmental and epileptic encephalopathy (DEE), two features that have never been associated with this condition. In addition, we reviewed the clinical features of all previous cases of MC4DN4 to give the other clinicians a wide picture of the clinical phenotype of this genetic disease. We hope that the publication of our data may help others to identify this disease and consider the chance to analyze the SCO1 gene in cases of DEE associated with pituitary dysfunction. Our article contributes to expanding the spectrum of genetic hypopituitarism and proposes a model to explain an association between this condition, mitochondrial anomalies, and neurodevelopmental defects.

Keywords: COX deficiency; SCO1 gene; developmental epileptic encephalopathy phenotypes; epilepsy; growth; hypopituitarism; pathogenic variant; short stature.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the study reported.

Figures

Figure 1
Figure 1
Brain MRI images: A, B, C patient n1, D, E, F patient n2. (A, D) sagittal T1-weighted image; (B, E) coronal T2-weighted image; (C, F) axial FLAIR T2-weighted image. The study shows cerebellar atrophy (white arrow), cerebral atrophy with widening of the Sylvian fissures, bilateral superior olivary nuclei increased signal on FLAIR and T2-weighted images (arrowhead), and posterior parietal and cerebellar white matter hyperintensity on FLAIR and T2-weighted images (empty arrow).
Figure 2
Figure 2
(A) Location on SCO1 gene of the two identified mutations modified from Valnot et al.; (B) 3D model of SCO1 protein with mutation site c.685 G>A (p.Gly229Ser); (C) 3D model of SCO1 protein with mutation site c.424C>G (p.Leu142Val). 3D models were realized with AlphaFold on www.uniprot.org.

References

    1. Brischigliaro M & Zeviani M. Cytochrome c oxidase deficiency. Biochimica et Biophysica Acta. Bioenergetics 20211862148335. (10.1016/j.bbabio.2020.148335) - DOI - PubMed
    1. Dimauro S Tanji K & Schon EA. The many clinical faces of cytochrome c oxidase deficiency. Advances in Experimental Medicine and Biology 2012748341–357. (10.1007/978-1-4614-3573-0_14) - DOI - PubMed
    1. Leary SC Kaufman BA Pellecchia G Guercin GH Mattman A Jaksch M & Shoubridge EA. Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase. Human Molecular Genetics 2004131839–1848. (10.1093/hmg/ddh197) - DOI - PubMed
    1. Valnot I Osmond S Gigarel N Mehaye B Amiel J Cormier-Daire V Munnich A Bonnefont JP Rustin P & Rötig A. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. American Journal of Human Genetics 2000671104–1109. (10.1016/S0002-9297(0762940-1) - DOI - PMC - PubMed
    1. Stiburek L Vesela K Hansikova H Hulkova H & Zeman J. Loss of function of Sco1 and its interaction with cytochrome c oxidase. American Journal of Physiology-Cell Physiology 2009296C1218–C1226. (10.1152/ajpcell.00564.2008) - DOI - PubMed